LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Pappas Capital Strengthens Investment Team With Appointments Of Cookie Yu And Gilbert Kinsey To Principal
RESEARCH TRIANGLE PARK, N.C., Dec. 1, 2021 -- Pappas Capital, a leading investor in early-stage life science and technology companies, today announced the promotions of Cookie Yu, PhD, and Gilbert Kinsey, PhD, PharmD, to Principal. Their promotions further strengthen the Pappas Capital team in support of the firm's continued growth and expansion.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.